Yesterday we discussed in-house options for replacing Kodai Senga temporarily while his shoulder recovers. We examined four possible candidates without considering the unproven rookies, but now that list is down to a trio with Max Kranick's hamstring injury already pushing him to the IL.
One of the names mentioned as a tier 2/tier 3 option is Michael Lorenzen, a one-time All Star who is available in free agency. The converted outfielder began his big league career as a starting pitcher, then was shifted to the bullpen for the next several seasons before returning to starting again in 2022. Last year in Detroit he started off quite well and was recognized for his efforts with a trip to the midsummer classic as a player and not merely a spectator. He then got shipped to the Phillies in a July trade and hit the road running with a no-hitter.
Unfortunately, then his magical season kind of fell apart. With the Phillies in 2023 he was 4-3 with a 5.51 ERA. He gave up more hits than innings pitched, struck out very few, walked too many and sported an ugly 1.458 WHIP for the season. It is not surprising, therefore, that the Phillies did not lock him up for 2024, particularly when he was earning $8.5 million for his paltry effort last year.
Over the course of his career Lorenzen has not been awful with a 40-38 records, a 4.11 ERA and moderate control to go along with moderate strikeout ability. The question, of course, is what is he worth and is he actually any better than the in-house options? At this late date he might get a split contract or a minor league deal with an invitation to the major league camp, but no one is breaking down his door for a hot half season in an otherwise very ordinary major league performance record.
The other player mentioned in this group was Mike Clevinger who has some off-the-field issues around his personality which could potentially disuade some potential suitors for his service in the starting rotation. Let's get these issues up on the table front and center. He has been accused of domestic violence based upon the word of one of the mothers of his children. She provided photographic evidence of a bruise allegedly created when Clevinger threw an iPad at her while she was pregnant. That accusation alone didn't trigger the MLB investigation.
She also stated that Clevinger was a user of illegal drugs, guilty of abuse of his young child as well, having thrown tobacco chew on him and having engaged in other non-specified acts of direct abuse or neglect that prompted baseball to investigate exactly what was going on with this pitcher. Say what you will about the league and how it treats players who allegedly violate the rules and laws, but Clevinger did not get any disciplinary action for these allegations.
Now, how does this guy perform his trade on the mound? Frankly, he's a bit better than Michael Lorenzen. For his 8-year career split between the Indians, Padres and White Sox Clevinger has a winning record as a starting pitcher, 60-39. He has a 3.45 career ERA and a roughly 3:1 strikeout to walk ratio with better than 1 per IP. His WHIP is below 1.200.
For this effort Clevinger was last paid $8 million before the ChiSox opted to buy out his 2024 contract for $4 million. That means theoretically he should be on the market for roughly $4 million between what he's already being paid and the black cloud regarding the personal behavior off the field. In 2023 overall he was 9-9 with a 3.77 ERA. It was not his best year but it's certainly better than what might be expected from the in-house options. Given his long term track record of pitching effectively and the potential to pay less for him than Lorenzen, he would seem to be the better mound option if you believe the MLB ruling of no abuse.
Morning all
ReplyDeleteThank you for giving us a deep dive on these guys. Frankly, in my opinion, they bring around the same to the table for what the Mets have in the secondary stable
Don't worry about Senga. Just resting a very talented arm
Severino looks good and love the 98
We'll get our first look at Manaea today
And Megill looks like a new guy with that funky new pitch.
Ample rotation for a team in transition to youth and the future
I am happy with the rotation, for essentially the same reason as Mack. Vasil, Scott, and Hamel edge ever closer.
ReplyDeletePrices seem to be dropping, so perhaps a bat for a one year deal? But Jett, Lusisangel, and Drew edge ever closer. I’m much more anxious to see if the Mets can get under the cap for 2025, so every player isn’t costing twice their salary.
The Yankees went bold, as they typically do, and so far this spring, Juan Soto has 2 HR,2 doubles, and 2 walks in 8 PAs.
Now THAT would have made the line up fearsome.
If the Giants offered back Davis for either Baty or Vientos, would you do it
ReplyDeleteHave to say I am getting closer to giving up on Baty
DeleteI tend to agree with the prior commenters in that these guys are no better than what is already in-house. Too, I don’t like the CBT fees and penalties. For signing Matt Chapman, the Giants are forfeiting $500K in international signing money, besides the second rounder and fourth. If they sign Snell it’s another $500K and the third and fifth rounder. That’s ridiculous! Well, if the Mets do it, they lose $1MM in Internation signing allotment and I believe their #1? Still, not interested in those penalties. BTW, did anyone read that Scherzer is also out until June or July with his herniated disk? If you’re scoring at home, that’s Verlander, Scherzer and DeGrom out for now.
ReplyDeleteFor those of you clamoring for information about the pitching lab, The Athletic has feedback from several of the pitchers that visited it.
ReplyDeleteI read that yesterday, and e-mailed the article to Mack. It wasn't very thotough, but interesting.
DeleteHas anyone here heard anything about the invisible Joey Wendle? He has yet to appear in a game, with the bat or glove, but I haven't seen any injury report.
ReplyDeleteBill, I’m puzzled like you. We need a good Wendle Stat.
ReplyDelete